MINNEAPOLIS, March 16, 2016 (GLOBE NEWSWIRE) -- MOCON, Inc. (Nasdaq:MOCO) announced today that Robert L. Demorest, President and Chief Executive Officer, and Elissa Lindsoe, Chief Financial Officer, will be presenting on behalf of MOCON at the 2016 Sidoti Emerging Growth Convention to be held in the Broadway Ballroom of the Marriott Marquis in New York, NY on Thursday, March 31st, 2016.
|Event:||Sidoti Emerging Growth Convention|
|When:||Thursday, March 31, 2016|
|Where:||New York Marriott Marquis – 6th Floor|
|1535 Broadway, New York, NY 10036 (45th & Broadway)|
MOCON is scheduled to deliver a presentation from 2:00 - 2:30 pm EDT followed by a Q&A with the audience. Admission is open to both institutional and retail investors.
To schedule a one-on-one meeting with management, please contact John DeBono at firstname.lastname@example.org or 212-894-3313.
Those interested in attending the event should call 212-453-7031 or email email@example.com to register.
About the Sidoti Emerging Growth Convention
The 2016 Sidoti Emerging Growth Convention is a unique forum where management teams of companies with a market cap of $1 billion or less connect with small and micro-cap institutional investors, research analysts, investment bankers, private equity professionals and select media with the goal of expanding institutional awareness amongst key stakeholders in the investment community. The 2016 Emerging Growth Conference will be held on March 31, 2016 at the Marriott Marquis in Times Square, New York. The event is one of the leading small and micro-cap investment conferences of the year featuring presentations by more than 80 public companies, with past attendance exceeding 400 investors.
About Sidoti & Company, LLC
A leading provider of institutional-quality equity research focused on small, publicly-traded companies that meet our proprietary criteria, Sidoti’s research coverage universe comprises nearly 300 companies across a range of industries. These companies typically have market capitalizations of less than $3 billion and a history of profitability, and generally maintain strong balance sheets. Our approach affords institutional investor clients a combination of high-quality research; a small- and micro-cap company focused nationwide sales effort; broad access to corporate management teams and extensive trading support.
MOCON is a leading provider of detectors, instruments, systems and consulting services to research laboratories, production facilities, and quality control and safety departments in the medical, pharmaceutical, food and beverage, packaging, environmental, oil and gas and other industries worldwide. See www.mocon.com for more information.